Methionine metabolism and phenotypic variability in X-linked adrenoleukodystrophy

M. Linnebank, S. Kemp, R. J. A. Wanders, W. J. Kleijer, M. L. T. van der Sterre, J. Gärtner, K. Fliessbach, A. Semmler, P. Sokolowski, W. Köhler, U. Schlegel, S. Schmidt, T. Klockgether, U. Wüllner

Research output: Contribution to journalArticleAcademicpeer-review

14 Citations (Scopus)

Abstract

A combined genotype of polymorphisms of methionine metabolism has been associated with CNS demyelination in methotrexate-treated patients. Within a sample of 86 patients with X-linked adrenoleukodystrophy, this genotype was overrepresented in a subgroup of 15 patients with adrenomyeloneuropathy (AMN) with CNS demyelination (adrenoleukomyeloneuropathy) in comparison to 49 AMN patients without CNS demyelination ("pure" AMN; p = 0.002), suggesting that methionine metabolism might contribute to the phenotypic variability in adrenoleukodystrophy
Original languageEnglish
Pages (from-to)442-443
JournalNeurology
Volume66
Issue number3
DOIs
Publication statusPublished - 2006

Cite this